Clinical features in very early-onset demyelinating disease with anti-MOG antibody.
Nishiyama M, Nagase H, Matsumoto M, Tomioka K, Awano H, Tanaka T, Toyoshima D, Fujita K, Maruyama A, Oyazato Y, Saeki K, Shiraishi K, Takada S, Kaneko K, Takahashi T, Nakashima I, Iijima K.
Nishiyama M, et al. Among authors: matsumoto m.
Brain Dev. 2017 Oct;39(9):756-762. doi: 10.1016/j.braindev.2017.05.004. Epub 2017 May 24.
Brain Dev. 2017.
PMID: 28551039